Excessive IL-1 production leads to pathological inflammation in autoimmune and autoinflammatory diseases such as rheumatoid arthritis (RA), systemic juvenile idiopathic arthritis (sJIA), and cryopyrin-associated periodic syndromes (CAPS) [2,3,4]. This evidence concerns the gene IL1A and cryopyrin-associated periodic syndrome.